Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARAMEL phase 2 trial of cannabidiol for alcohol use disorder
2019-004740-30Phase 2Active
- Sponsor
- Centre Hospitalier Le Vinatier
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing cannabidiol with placebo (2 arms). Primary endpoint: Change in total alcohol consumption over 28 days. Started Jan 2022; status: active.
02
Drugs
cannabidiol
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2019-004740-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004740-30.